3.17
+0.01(+0.32%)
Currency In USD
| Previous Close | 3.16 |
| Open | 3.12 |
| Day High | 3.17 |
| Day Low | 3.12 |
| 52-Week High | 10.16 |
| 52-Week Low | 1.92 |
| Volume | 1,358 |
| Average Volume | 33,236 |
| Market Cap | 8.07M |
| PE | -1.47 |
| EPS | -2.16 |
| Moving Average 50 Days | 3.41 |
| Moving Average 200 Days | 3.61 |
| Change | 0.01 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $396.25 as of July 01, 2025 at a share price of $3.17. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $48.62 as of July 01, 2025 at a share price of $3.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
GlobeNewswire Inc.
Jun 26, 2025 12:19 PM GMT
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track recor
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
GlobeNewswire Inc.
Jun 06, 2025 1:30 PM GMT
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financingMr. Chin’s appointment strength
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
GlobeNewswire Inc.
Jun 05, 2025 12:19 PM GMT
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an effective p